These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 789088)

  • 1. Production of migration inhibitory factor and lymphotoxin by non-T cells.
    Bloom BR; Stoner G; Gaffney J; Shevach E; Green I
    Eur J Immunol; 1975 Mar; 5(3):218-20. PubMed ID: 789088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of immunoglobulin-bearing lymphocytes in the production of macrophage migration inhibitory factor.
    Pick E; Godny Y; Gold EF
    Eur J Immunol; 1975 Aug; 5(8):584-7. PubMed ID: 789092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that Ia-antigens are not secreted by antigen or mitogen stimulated mouse or guinea pig lymphocytes.
    Sorg C; Geczy CL; Geczy AF; Hämmerling GJ; Gately M
    Z Immunitatsforsch Immunobiol; 1978; 154(1):44-61. PubMed ID: 341556
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
    Neumann C; Sorg C
    Eur J Immunol; 1978 Aug; 8(8):582-9. PubMed ID: 359337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. IV. Characterization of migration inhibition factor-producing lymphocytes and genetic requirements for activation.
    Moorhead JW; Murphy JW; Harvey RP; Hayes RL; Fetterhoff TJ
    Eur J Immunol; 1982 May; 12(5):431-6. PubMed ID: 7047175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of T-cells synthesizing macrophage migration inhibition factor in an H-2 system].
    Suslov AP; Brondz BD; Egorova SG
    Biull Eksp Biol Med; 1978 Jun; 85(6):701-4. PubMed ID: 352434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
    Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
    J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of B cell MIF production by T cells and soluble T cell-derived factors.
    Cohen S; Yoshida T
    J Immunol; 1977 Aug; 119(2):719-21. PubMed ID: 328780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of lymphocyte mitogen from lymphotoxin and experiments on the production of lymphotoxin by lymphoid cells stimulated with the partially purified mitogen: a possible amplification mechanism of cellular immunity and allergy.
    Gately CL; Gately MM; Mayer MM
    J Immunol; 1976 Mar; 116(3):669-75. PubMed ID: 1082890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Participation of spleen cells in regulating the production of macrophage migration inhibitory factor in mice].
    Koval'chuk LV; Sotnikova NIu
    Biull Eksp Biol Med; 1981 Mar; 91(3):336-8. PubMed ID: 7018617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal dependence of the inhibition by cytochalasin B of antigen-initiated migration inhibition factor production.
    Sasson SZ; Rosenthal AS
    J Immunol; 1975 Oct; 115(4):1140-2. PubMed ID: 1100722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.
    Winkelstein A
    J Clin Invest; 1975 Dec; 56(6):1587-96. PubMed ID: 1081551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further characterization of antigen-dependent migration inhibition factor in mice.
    Hochova B; Krejcí J; Pekarek J; Svejcar J; Johanovsky J
    Immunology; 1975 Aug; 29(2):231-6. PubMed ID: 1098999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly phenotype of lymphocytes producing murine migration inhibitory factor (MIF).
    Kühner AL; Cantor H; David JR
    J Immunol; 1980 Sep; 125(3):1117-9. PubMed ID: 6997376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte trapping. Differential effects of ATS and irradiation on trapping in lymph nodes and spleen.
    Zatz MM
    Immunology; 1976 May; 30(5):749-53. PubMed ID: 1084322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.